Medicines Co. (MDCO) Tops Q1 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. DOX
4. AMGN
5. DUOL
6. FIS
7. ANET
8. CVS
9. SWKS
10. SPY

Go back to Medicines Co. (MDCO) Tops Q1 EPS by 2c

The Medicines Company Reports First-Quarter 2018 Results

April 25, 2018 7:00 AM EDT

PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ: MDCO) today reported its financial results for the first quarter ended March 31, 2018.

During the first quarter of 2018, The Medicines Company continued to demonstrate strong clinical and operational execution, significantly advancing the ORION development programs for our investigational agent, inclisiran, and delivering against all of our other 2018 objectives, said Clive Meanwell, M.D., Ph.D., Chief Executive Officer of The Medicines Company.

First quarter 2018 highlights included:

In January, the Company completed the sale of its infectious disease business unit to Melinta... More